Table 1

Schedule of enrolment, interventions and assessments

Study period
EnrolmentAllocationPostallocationClose-out
Timepoint (days)000 to 28 maximum28 maximum
Enrolment
 Eligibility screenX
 Express consentX
 AllocationX
Interventions
 HFHOX
 Standard O2 X
Assessments
Baseline variables
  DemographicsX
  Medical historyX
  Clinical examinationX
  Paraclinical examination
  (pH, SOFA score)
  SAPS II score
  ECG–chest X-ray)
  ACRF aetiology
X
Outcomes variables
  NIV durationX
  HFHO or standard O2 duration according to group allocationX
  Intubation/reintubationX
  Vital statusXX
  VAS comfort after 1 hour of NIV resumptionX
  VAS dyspnoea after 1 hour of NIV resumptionX
  Likert scale for comfort after 1 hour of NIV resumptionX
  Likert scale for dyspnoea after 1 hour of NIV resumptionX
  VAS comfort after 2 hours of SB resumption*X
  VAS dyspnoea after 2 hours of SB resumption*X
  Likert scale for comfort after 2 hours of SB resumption*X
  Likert scale for dyspnoea after 2 hours of SB resumption*X
  Respiratory rate after 1 hour of NIV resumptionX
  Respiratory rate after 2 hours of SB resumption*X
  Daily ABGX
  Adverse eventsX
  Hospital length of stayX
Other variables
  Criteria for switching between NIV and SBX
  Criteria to definitely stop NIVX
  Criteria for intubationX
  Discharge conditionsX
  • *Two hours of SB in the first 48 hours postrandomisation, and 4 hours thereafter.

  • ABG, arterial blood gas; ACRF, acute-on-chronic respiratory failure; HFHO, high flow heated and humidified nasal oxygen; NIV, non-invasive ventilation; SAPS II, simplified acute physiology score II; SB, spontaneous breathing; SOFA, sequential organ failure assessment; VAS, Visual Analogue Scale.